A study published in Hepatology found that patients with chronic hepatitis C virus who consumed more than 308mg of caffeine daily had milder liver fibrosis. The protective effect was greatest when caffeine came from coffee sources, suggesting a potential therapeutic benefit for moderate coffee consumption.
A recent study found that repeated liver stiffness measurements can accurately detect severity of fibrosis in patients with hepatitis C recurrence after a liver transplant. Slow 'fibrosers' progressed at the same rate as non-HCV LT patients, while rapid 'fibrosers' showed significant fibrosis and portal hypertension early on.
Researchers have identified two cellular proteins that are important factors in hepatitis C virus infection. The natural compound Quercetin inhibits the synthesis of these proteins, significantly inhibiting viral infection in tissue culture. A Phase I clinical trial will be launched to determine if the compound is safe and effective.
Peliosis hepatis, a rare pathological entity, can lead to spontaneous liver rupture, a life-threatening condition that necessitates prompt medical intervention. The case report highlights the importance of considering PH in patients with risk factors, emphasizing the need for early diagnosis and treatment to prevent severe complications.
Researchers used EUS with contrast-enhanced harmonic imaging to diagnose small pancreatic carcinomas. Periodic follow-ups revealed accurate diagnosis of disease progression in patients with branch duct intraductal papillary mucinous neoplasm (IPMN).
A new study demonstrates that muscle cells grown in the lab can restore an intestine's ability to squeeze shut properly. The technique may strengthen sphincters, which are bands of muscle separating intestinal sections, and treat conditions like gastric reflux and fecal incontinence.
A new study published in Clinical Gastroenterology and Hepatology found that combining sigmoidoscopy and fecal immunochemical test (FIT) improves CRC detection by 10 percent. This combination is particularly useful for communities with limited colonoscopy access, as it allows for more effective screening of advanced proximal tumors.
Research suggests that only half of Americans with hepatitis C virus infection are aware of their diagnosis, leading to a decline in antiviral therapy treatment rates. By 2030, less than 15% of liver-related deaths from HCV will be prevented by antiviral therapy if the trend continues.
A recent metobolomics study found that impaired peroxisomal oxidation of polyunsaturated fatty acids is associated with progression to NASH. The study also revealed significantly higher plasma monounsaturated fatty acids in patients with NAFL and NASH.
A new report from gastroenterology/hepatology societies emphasizes the importance of competency-based curriculum and disease-specific training in improving patient outcomes. The report recommends changes to GI training programs, including pairing of GI/hepatology training and enhanced training in specific disease areas.
A new UCLA study found that early-morning colonoscopies yielded more polyps per patient than later screenings, while the amount of polyps discovered decreased hour by hour as the day progressed. This suggests a need for broader system changes to improve outcomes for colonoscopy procedures.
A common type of chronic diarrhoea, affecting one in 100 people in the UK, may be caused by a hormone deficiency. The study suggests that bile acid production is linked to decreased levels of Fibroblast Growth Factor 19 (FGF19) in people with the condition.
Researchers discovered Snail and Twist are the major inducers of EMT in HCC, associated with reduced E-cadherin function and larger tumor size. The study provides essential information for determining liver cancer prognosis and identifying potential new treatments.
Patients with chronic hepatitis C who drink three or more cups of coffee per day have a lower risk of liver disease progression compared to non-coffee drinkers. The study found no association between tea intake and liver disease progression.
A case of post-gastrectomy acute pancreatitis was reported in a patient with gastric carcinoma and pancreas divisum. Early detection and aggressive treatment may improve prognosis for patients with this condition. The study highlights the importance of monitoring pancreatic function after gastrectomy.
Researchers at the University of Southampton discovered a link between a mother's high-fat diet during pregnancy and her child's development of fatty liver disease. The study found that a high-fat diet can affect the developing liver of a fetus, making it more susceptible to fatty liver disease later in life.
A UNC study found that using audio recordings of guided imagery at home in addition to standard medical treatment can significantly reduce abdominal pain in children. The benefits were maintained for six months after treatment ended, highlighting the potential of self-administered treatment as a cost-effective and accessible option.
A study published in the World Journal of Gastroenterology evaluated 76 cases of living donor liver transplantation and found that the Chengdu formula is reliable. The other formulas, such as Fan and Heinemann, underestimated liver volume, while Urata and Lee overestimated it.
Researchers at UC Riverside found that second-hand cigarette smoke exposure can lead to fat accumulation in liver cells, causing nonalcoholic fatty liver disease (NAFLD). The study highlights the potential for targeting molecular regulators SREBP and AMPK to develop new treatments for NAFLD.
Cirrhotic patients with minimal hepatic encephalopathy (MHE) are at a higher risk of motor vehicle accidents, with a 16% rate compared to 4% for those without MHE. A study found that ICT was a superior test in identifying patients at risk of future auto accidents.
Researchers found that 4 weeks of aerobic cycling exercise reduced hepatic triglyceride concentration and visceral adipose tissue volume in obese individuals, leading to lower risk of nonalcoholic fatty liver disease. This study suggests that regular physical activity can benefit liver health without relying on weight loss.
Researchers found that acid refluxing at night results in sleep arousal 89 percent of the time in participants with and without GERD. GERD patients experience longer acid reflux events, leading to increased risk for complicated disease and esophageal cancer. This association suggests a bi-directional link between sleep problems and GERD.
Researchers at Mayo Clinic found high-dose ursodeoxycholic acid to be detrimental in treating primary sclerosing cholangitis. The six-year trial showed that serious adverse events were more common in the high-dose group, highlighting the need for further research on better treatment options.
A recent study led by Keith Lindor found that patients with primary sclerosing cholangitis (PSC) who received high-dose ursodeoxycholic acid experienced poorer clinical results compared to those receiving a placebo. The therapy was associated with an increased risk of death, transplantation, and liver damage.
A recent study found carvedilol to be more effective in preventing variceal bleeding in cirrhotic patients compared to traditional treatment with variceal band ligation. The results showed that carvedilol reduced the risk of bleeding by 10% compared to VBL, while survival rates remained unchanged.
A spot urine test has been developed to monitor dietary sodium compliance in patients with liver disease and ascites. The study found adequate accuracy for the spot urine test, making it a valuable tool for identifying non-compliant patients.
Three cases of patients with liver injury and renal failure have been reported due to steroid-enriched dietary supplements. Researchers warn that even low doses of anabolic steroids can cause severe health consequences.
A study found that patients satisfied with their GERD treatment had better health-related quality of life and were more likely to be taken seriously by their physicians. The quality of patient-physician communication was also a key factor in patient satisfaction.
A study found that S-adenosylmethionine (SAMe) prevents the formation of hepatocellular carcinoma (HCC) in rats, with a 1cm tumor reduced in size after treatment. However, high doses were not sufficient to treat established HCC cases, as the liver compensates for SAMe accumulation by metabolizing it.
Studies reveal that hepatitis C virus carriers have a significant increase in mortality, with liver-related deaths being the leading cause. The research found that monitoring HCV load and ALT levels may be crucial for identifying high-risk individuals, particularly older carriers who are less responsive to treatment.
A study found that adjusting the Fibroscan probe position can significantly alter liver stiffness measurements, with potential implications for diagnosing advanced fibrosis and cirrhosis. The researchers suggest a more anterior probe position may improve test applicability and reduce false positives.
Researchers discovered elevated populations of NK cells in the bile ducts of infants with biliary atresia, which led to tissue damage. Blocking the Nkg2d receptor and depleting NK cells prevented damage to bile duct surface tissues.
A $15 million NIH grant will support a five-year research consortium at Massachusetts General Hospital to study how the hepatitis C virus evades the immune system. The project aims to improve understanding of liver cell involvement in HCV infection and develop new treatments for chronic viral infections.
A study found that diets high in protein and cholesterol increase the risk of hospitalization or death due to cirrhosis or liver cancer, while those high in carbohydrates reduce the risk. The study also identified associations between dietary nutrient composition and liver disease progression.
A new study found that exercise counseling leads to significant improvements in physical activity, fitness, and liver health in patients with nonalcoholic fatty liver disease. Patients who increased their physical activity had better metabolic indices, including lower liver enzymes and improved insulin resistance.
The European Association for the Study of the Liver (EASL) has renewed its publishing partnership with Elsevier for five years, with the flagship journal Journal of Hepatology being published monthly. EASL is a leading liver association in Europe, promoting research and education in hepatology.
A study published in the World Journal of Gastroenterology found that preoperative biliary drainage significantly reduced wound infection rates in patients undergoing resectional surgery for ampullary carcinoma. The findings suggest that PBD may have a positive impact on surgical outcomes, particularly in terms of infectious morbidity.
Researchers at Ohio State University have identified two potential anti-cancer agents that target multiple genes associated with invasive liver cancer behavior. The compounds, Resveratol and 17-allylamino-geldanamycin (17-AAG), may reverse gene changes linked to tumor progression.
A new combination therapy of daily consensus interferon and ribavirin has been found to be effective in some hepatitis C patients who have not responded to previous treatment. The study, led by a Saint Louis University researcher, showed a success rate of above 30 percent for patients with less severe liver damage.
A Phase IIb clinical trial shows that adding a hepatitis C protease inhibitor called telaprevir to standard therapy can significantly improve the chances of being cured, with a 67% cure rate in patients treated for 24 weeks. The treatment also reduces side effects and treatment duration compared to standard therapy alone.
A study found that complex antithrombotic therapy is associated with a high risk of upper gastrointestinal events among vulnerable elders. The researchers also discovered that proton pump inhibitors may increase the risk of hip fractures in patients taking acid suppressors.
Researchers found that private insurance patients had better weight loss outcomes and lower complication rates compared to Medicare patients. Duodenal switch surgery may be more effective than gastric bypass surgery for certain obesity-related medical problems, such as diabetes and high cholesterol.
Researchers present latest advances in Natural Orifice Translumenal Endoscopic Surgery (NOTES), eliminating incisions and reducing recovery time. Studies show promising results for procedures like cholecystectomy, appendectomy, and gastrectomy with fewer complications.
Two new studies present promising findings for hepatitis treatments, including a switch to Tenofovir Disoproxil Fumarate (TDF) for patients with persistent viral replication. The study also explores the long-term effects of Interferon Based Therapy on Hepatic Histology in Patients with Chronic Hepatitis C Virus, showing improved histol...
Researchers presented data on the effectiveness of monoclonal antibodies in treating Crohn's disease and preventing C. difficile recurrence, showing improved clinical outcomes and safety profiles.
Researchers explore health outcomes of IBD, finding increased radiation exposure among patients, especially those with Crohn's disease. Growth hormone therapy shows promise in reducing symptoms and improving disease activity in pediatric CD patients.
Death receptors, which eliminate unwanted cells, may also be used to strengthen cells against illnesses. Researchers can develop new therapeutics that target these receptors to treat various diseases.
A new study published in Clinical Gastroenterology and Hepatology suggests that obesity is an independent predictor of inadequate bowel preparation at colonoscopy. Patients with a higher Body Mass Index (BMI) are more likely to require more rigorous bowel preparation regimens.
Recent studies have shown that patients under deep sedation during colonoscopy are more likely to have large polyps detected, which could lead to earlier detection of colon cancer. Additionally, research suggests that removing advanced pre-malignant polyps sooner than recommended may be beneficial in reducing the risk of colon cancer.
Researchers presented two groundbreaking studies at DDW 2009: a text messaging system improved medication adherence in pediatric liver transplant recipients, reducing organ rejection and costs. A new non-invasive breath test accurately predicts long-term prognosis for patients with chronic liver disease.
A study suggests air pollution may contribute to non-specific abdominal pain in young women, while another study shows that moderate alcohol intake can reduce the risk of gallstones. The findings highlight the importance of environmental factors and lifestyle choices on GI health.
A study presented at DDW 2009 found that over one-third of US adults have liver disease, with some cases potentially attributed to environmental pollution. Researchers used the NHANES dataset to examine the association between low-level exposure to 111 common pollutants and unexplained liver disease in adults.
A new combination therapy of daily consensus interferon and ribavirin is effective for some people with chronic hepatitis C, particularly those with lower fibrosis scores. Nearly half of all HCV patients do not respond to standard therapy, and this treatment shows promise as an alternative.
Research reveals a strong association between nonalcoholic fatty liver disease (NAFLD) and both increased intestinal permeability and bacterial overgrowth in the small intestine. The study suggests that these factors contribute to the severity of steatosis, but not to more severe liver diseases like steatohepatitis or fibrosis.
A study investigated the link between high ferritin levels and steatosis in a non-obese cohort of non-alcoholic patients, finding hyperferritinemia as a surrogate marker of advanced liver disease. The research suggests that high ferritin levels are associated with low platelet count, steatosis and clinical relevance.
A new study published in Hepatology found that women with a history of hypothyroidism are at a significantly higher risk of developing liver cancer. The study revealed that subjects with a prior history of hypothyroidism had twice the risk of liver cancer, particularly for females, and those who had it for over 10 years had a threefold...
Researchers found that patients with chronic hepatitis C who have achieved a sustained viral response often still carry miniscule amounts of the virus in their bodies. These trace remainders are thought to be infectious, posing a risk to others.
A new study shows radioembolisation to be a safe and effective treatment for patients with advanced HCC, achieving partial response rates of up to 80% and comparable survival rates to systemic therapy. The technique may offer a novel palliative therapeutic approach for those with limited options.
A study by the University of California San Francisco found that US and foreign transplant physicians express serious concern about organ procurement in China, citing coercion of organ donors and substandard medical practices. The majority of doctors surveyed would not provide post-transplantation care to patients who underwent liver t...
A study found that sorafenib dramatically improved the condition of rats with portal hypertension, reducing new blood vessel growth and improving liver function. The results suggest that sorafenib may be an effective therapeutic agent for treating advanced portal hypertension.